2024-05-10T11:46:49-05:00 2023-12-31 872525370 CITRIN COOPERMAN ADVISORS LLC 180 PARK AVENUE SUITE 200 FLORHAM PARK NJ 07932 990EZ 2023-01-01 861682122 THE WITTEK RESEARCH FOUNDATION FOR HYPERTROPHIC CARDIOMYOPATHY INC WITT 9739782540 131 DOWNEY DRIVE TENAFLY NJ 076703005 PAMELA COHEN MD PRESIDENT AND FOUNDER 9739782540 2024-05-09 1 PAMELA COHEN MD 999009999 0 PAULA VUKSIC P00360739 9732180500 2024-05-09 3 AAL1 IAL1 2023 2023-04-26 12:10:37Z X WWW.WITTEKFOUNDATION.ORG X X 73921 X 73921 73921 33573 7479 41052 32869 38154 0 71023 38154 71023 38154 71023 0 0 38154 71023 X DEDICATED TO SUPPORTING RESEARCH THAT WILL TRANSFORM THE PREVENTION, DIAGNOSIS, AND TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY. THE SECOND ANNUAL MEETING OF THE WITTEK RESEARCH FOUNDATION FOR HYPERTROPHIC CARDIOMYOPATHY WAS HELD ON NOVEMBER 11, 2023 IN PHILADELPHIA. UNDER THE GUIDANCE OF THE MEMBERS OF OUR SCIENTIFIC ADVISORY BOARD, THE GOALS OF THIS HALF-DAY MEETING WAS TO IDENTIFY THE CURRENT STATE PATIENT REPORTING OUTCOME TOOLS AND STRATEGIES FOR FUTURE DEVELOPMENTS IN THIS AREA. PARTICIPANTS REPRESENTED CARDIOLOGISTS, PATIENT ADVOCATES, REPRESENTATIVES FROM THE PHARMACEUTICAL INDUSTRY AND THE FEDERAL DRUG ADMINISTRATION. 0 41019 41019 PAMELA COHEN MD PRESIDENT AND FOUNDER 20.00 0 0 0 SAM BLUMENSTYK JD TREASURER 2.00 0 0 0 PAMELA GOLDSTEIN JD SECRETARY 2.00 0 0 0 X 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NJ PAMELA COHEN MD 131 DOWNEY DRIVE TENAFLY NJ 076703005 9739782540 0 0 0 0 0 0 0 0 0 0 NONE NONE 1 X 76421 76421 76421 76421 25416 51005 76421 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED FORM 990-EZ, PART I, LINE 16 - OTHER EXPENSES DESCRIPTION: HONORARIUMS. AMOUNT: 4,000. DESCRIPTION: OFFICE EXPENSE. AMOUNT: 1,848. DESCRIPTION: SUPPLIES. AMOUNT: 453. DESCRIPTION: TRAVEL. AMOUNT: 1,178. TOTAL TO FORM 990-EZ, LINE 16: 7,479. THE ORGANIZATION DID NOT, DURING THE YEAR, RECEIVE ANY FUNDS, DIRECTLY,OR INDIRECTLY, TO PAY PREMIUMS ON A PERSONAL BENEFIT CONTRACT.THE ORGANIZATION, DID NOT, DURING THE YEAR, PAY ANY PREMIUMS, DIRECTLY,OR INDIRECTLY, ON A PERSONAL BENEFIT CONTRACT.